← Back to the library
BipolarJanuary 5, 2024 · 5 min read

Breaking Free from Schizophrenia & Bipolar: Lurasidone's Impact

Lurasidone is a medication that belongs to the class of atypical antipsychotics. It is used to treat schizophrenia and bipolar depression, which are mental disorders that affect a person’s mood, thoughts, and behavior. L...

Lurasidone for schizophrenia and bipolar disorder, illustrated with an unmarked tablet and blue-violet neural pathways
In this article

Lurasidone is a medication that belongs to the class of atypical antipsychotics. It is used to treat schizophrenia and bipolar depression, which are mental disorders that affect a person’s mood, thoughts, and behavior. Lurasidone is sold under the brand name Latuda and is available as tablets that are taken by mouth with food.

History

Lurasidone was first synthesized in 2003 by a Japanese pharmaceutical company called Dainippon Sumitomo Pharma. It was approved for medical use in the United States in 2010, in Canada and Europe in 2013, and in Japan in 2014. Lurasidone was developed as a novel antipsychotic with a unique pharmacological profile that differs from other atypical antipsychotics.

Mechanism of Action

Lurasidone works by affecting the activity of certain chemicals in the brain called neurotransmitters, such as dopamine and serotonin. These neurotransmitters are involved in regulating mood, cognition, and perception. Lurasidone acts as an antagonist of the dopamine D2 and D3 receptors, and the serotonin 5-HT2A and 5-HT7 receptors, which means that it blocks their effects. Lurasidone also acts as a partial agonist of the serotonin 5-HT1A receptor, which means that it stimulates it to a lesser extent than the natural neurotransmitter. By modulating these receptors, lurasidone may help to reduce the symptoms of schizophrenia and bipolar depression, such as hallucinations, delusions, mood swings, and suicidal thoughts.

Evidence for use

Lurasidone has been tested in several clinical trials for its efficacy and safety in treating schizophrenia and bipolar depression. The results of these trials have shown that lurasidone is effective in reducing the positive and negative symptoms of schizophrenia, such as psychosis, social withdrawal, and lack of motivation. Lurasidone has also been shown to improve the depressive symptoms of bipolar disorder, such as low mood, loss of interest, and hopelessness. Lurasidone has been compared to other antipsychotics, such as olanzapine, quetiapine, risperidone, and ziprasidone, and has been found to be similar or superior in terms of efficacy and tolerability.

Dosing

The recommended starting dose of lurasidone for schizophrenia is 40 mg once daily with food. The dose may be increased or decreased depending on the response and side effects of the patient. The maximum dose is 160 mg per day. The recommended starting dose of lurasidone for bipolar depression is 20 mg once daily with food. The dose may be increased up to 120 mg per day depending on the response and side effects of the patient. Lurasidone may be used alone or in combination with other mood stabilizers, such as lithium or valproate.

Side Effects/ Adverse reactions / Contradictions

Like all medications, lurasidone may cause some side effects. The most common side effects are sleepiness, movement disorders, nausea, and diarrhea. These side effects are usually mild and tend to decrease over time. Some serious side effects may occur rarely, such as neuroleptic malignant syndrome (a life-threatening condition characterized by fever, muscle rigidity, altered mental status, and high blood pressure), tardive dyskinesia (a potentially irreversible condition characterized by involuntary movements of the face, tongue, or limbs), high blood sugar levels (which may lead to diabetes or worsen existing diabetes), high cholesterol levels (which may increase the risk of heart disease), weight gain (which may increase the risk of obesity and metabolic syndrome), low blood pressure (which may cause dizziness or fainting), seizures (which may cause loss of consciousness or convulsions), allergic reactions (which may cause rash, itching, swelling, or difficulty breathing), and increased prolactin levels (which may cause breast enlargement or milk production in both men and women). Lurasidone should be used with caution in patients who have a history of heart disease, liver disease, kidney disease, epilepsy, diabetes, or low white blood cell count. Lurasidone should not be used in patients who are allergic to it or any of its ingredients. Lurasidone should not be used in combination with certain medications that may interact with it or affect its metabolism, such as strong inhibitors or inducers of an enzyme called CYP3A4. Examples of these medications include ketoconazole (an antifungal drug), ritonavir (an antiviral drug), rifampin (an antibiotic drug), grapefruit juice (a fruit drink), and St. John’s wort (an herbal supplement). Lurasidone should not be used in pregnant or breastfeeding women, as it may harm the unborn or nursing baby. Lurasidone should not be used in children or adolescents under 10 years of age, as its safety and effectiveness in this age group have not been established.

Positives or Pros

Lurasidone has several advantages over other antipsychotics, such as:

  • It has a favorable metabolic profile, meaning that it is less likely to cause weight gain, diabetes, or high cholesterol levels than other antipsychotics.
  • It has a low risk of causing sedation, cognitive impairment, or sexual dysfunction than other antipsychotics.
  • It has a high affinity for the serotonin 5-HT7 receptor, which may contribute to its antidepressant and cognitive-enhancing effects.
  • It has a low risk of causing QT prolongation, which is a potentially dangerous abnormality in the heart rhythm that may lead to cardiac arrhythmias or sudden death.

Negatives or Cons

Lurasidone also has some disadvantages over other antipsychotics, such as:

  • It has to be taken with food, preferably a meal of at least 350 calories, to ensure adequate absorption and bioavailability. This may limit its convenience and adherence for some patients.
  • It has a relatively long half-life, meaning that it takes a long time to be eliminated from the body. This may increase the risk of accumulation and toxicity if the dose is missed or changed.
  • It has a high potential for drug interactions, as it is extensively metabolized by the CYP3A4 enzyme. This means that it may interact with many other medications that are either substrates, inhibitors, or inducers of this enzyme. This may require dose adjustment or avoidance of certain medications when using lurasidone.
  • It has a moderate risk of causing extrapyramidal symptoms, such as tremor, stiffness, restlessness, or abnormal movements. These symptoms may be distressing and impairing for some patients.

Conclusion

Lurasidone is a novel atypical antipsychotic that has been shown to be effective and well-tolerated in the treatment of schizophrenia and bipolar depression. It has a unique pharmacological profile that may offer some advantages over other antipsychotics in terms of metabolic, cognitive, and cardiac effects. However, it also has some limitations in terms of dosing, elimination, and drug interactions that may require careful monitoring and management. Lurasidone may be a valuable option for patients who have not responded well to other antipsychotics or who have experienced intolerable side effects from them.

By Birk Gundersen RN, BSN.

Sources

1: Lurasidone - Wikipedia

2: Lurasidone: MedlinePlus Drug Information

3: Lurasidone Uses, Side Effects & Warnings - Drugs.com 4

Words worth knowing

Cognitive behavioral therapy (CBT)

A structured therapy that helps people notice patterns between thoughts, feelings, and actions, then practice more helpful responses.

Sources

  1. msn.com
  2. en.wikipedia.org
  3. medlineplus.gov
  4. medlineplus.gov
  5. drugs.com
Educational content—not medical advice.Find support resources →